Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2023 |
| Income Tax Disclosure [Abstract] |
|
| Schedule of Net Income (Losses) Before Income Taxes |
Net income (losses) before income taxes for the years ended December 31, 2023 and 2022 was as follows: | | | | | | | | | | | | | For the years ended December 31, | | 2023 | | 2022 | | U.S. | $ | (229,585) | | | $ | (229,923) | | | Non-U.S. | 110 | | | 161 | | | Total income (loss) before income tax | $ | (229,475) | | | $ | (229,762) | |
|
| Schedule of Components of Income Tax Expense (Benefit) |
Income tax expense (benefit) was as follows: | | | | | | | | | | | | | For the years ended December 31, | | 2023 | | 2022 | | Current expense (benefit): | | | | | U.S. federal | $ | — | | | $ | — | | | U.S. state and local | — | | | — | | | Non-U.S. | 31 | | | 51 | | | Total current income tax (benefit) provision | $ | 31 | | | $ | 51 | | | Deferred expense (benefit): | | | | | U.S. federal | $ | — | | | $ | — | | | U.S. state and local | — | | | — | | | Non-U.S. | — | | | — | | | Total deferred income tax (benefit) provision | — | | | — | | | Total income tax (benefit) provision | $ | 31 | | | $ | 51 | |
|
| Schedule of Reconciliation from Statutory U.S. Federal Income Tax Rate to Effective Tax Rate |
The reconciliation from the statutory U.S. federal income tax rate to the effective tax rate is as follows: | | | | | | | | | | | | | For the years ended December 31, | | 2023 | | 2022 | | Income (loss) before income taxes | $ | (229,475) | | | $ | (229,762) | | | | | | | Statutory U.S. federal income tax (21%) | (48,190) | | | (48,250) | | | State and local income tax | 330 | | | (12,051) | | | Income taxed at rates other than statutory | 8 | | | 17 | | | Non-deductible convertible debt | 8,420 | | | (2,220) | | | Non-deductible warrant cost | (5) | | | (178) | | | Stock-based compensation | 1,687 | | | 1,622 | | Non-deductible officers compensation | 2,580 | | | — | | | Valuation allowance | 34,821 | | | 60,444 | | | Other | 380 | | | 667 | | | Total income tax expense | $ | 31 | | | $ | 51 | | | Effective tax rate | — | | | — | |
|
| Schedule of Components of Deferred Tax Assets and Liabilities |
The components of deferred tax assets and liabilities at December 31, 2023 and 2022 were as follows: | | | | | | | | | | | | | December 31, | | 2023 | | 2022 | | Deferred tax assets: | | | | | NOL carryforwards | $ | 152,380 | | | $ | 121,142 | | | Capital loss carryforwards | 235 | | | 235 | | | Tax credit carryforwards | 65 | | | 65 | | | Goodwill | 6,735 | | | 7,427 | | | Capitalized research & experimental costs | 8,213 | | | 3,952 | | | Stock-based compensation | 3,819 | | | 4,819 | | | Accruals and reserves | 2,503 | | | 1,678 | | | Organizational costs | 124 | | | 140 | | | Lease liability | 1,309 | | | 1,413 | | | Fixed assets | 268 | | | 316 | | | | | | | Inventory | 977 | | | 663 | | | Transaction costs | 244 | | | 266 | | | Deferred tax assets, gross | $ | 176,872 | | | $ | 142,116 | | | Valuation allowance | (175,680) | | | (140,858) | | | Total deferred tax assets, net | $ | 1,192 | | | $ | 1,258 | | | Deferred tax liabilities: | | | | | | | | | Right of use asset | (1,144) | | | (1,194) | | | | | | | Intangibles | (41) | | | (63) | | | Other | (7) | | | (1) | | | Deferred tax liabilities | (1,192) | | | (1,258) | | | Total deferred tax asset (liability) | $ | — | | | $ | — | |
|
| Schedule of Unrecognized Tax Benefits Associated with Uncertain Tax Positions |
The Company has unrecognized tax benefits associated with uncertain tax positions as of December 31, 2023 and 2022 as follows: | | | | | | | | | | | | | For the years ended December 31, | | 2023 | | 2022 | Gross unrecognized tax benefits as of January 1 | $ | 685 | | | $ | 719 | | | Additions: | | | | | Current year tax positions | — | | | — | | | Prior year tax positions | — | | | — | | | Rate change | (5) | | | (34) | | | Settlements | — | | | — | | | Lapse of statute of limitations | — | | | — | | | Gross unrecognized tax benefits as of December 31 | $ | 680 | | | $ | 685 | |
|